Reference 33 2016
Rosenquist R, Stamatopoulos K: B-cell malignancies: All roads lead to NF-κB activation. Semin Cancer Biol. 2016 Aug;39:1-2. Epub 2016 Aug 18. PubMed PMID: 27546288. doi: http://dx.doi.org/10.1016/j.semcancer.2016.08.003
Reference 34 2016
Mansouri L, Papakonstantinou N, Ntoufa S, Stamatopoulos K, Rosenquist R: NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions. Semin Cancer Biol. 2016 Aug;39:40-8. Epub 2016 Aug 1. Review. PubMed PMID: 27491692. doi: http://dx.doi.org/10.1016/j.semcancer.2016.07.005
Reference 35 2016
Navrkalova V, Young E, Baliakas P, Radova L, Sutton LA, Plevova K, Mansouri L, Ljungström V, Ntoufa S, Davis Z, Juliusson G, Smedby KE, Belessi C, Panagiotidis P, Touloumenidou T, Davi F, Langerak AW, Ghia P, Strefford JC, Oscier D, Mayer J, Stamatopoulos K, Pospisilova S, Rosenquist R, Trbusek M: ATM mutations in major stereotyped subsets […]
Reference 36 2016
Ntoufa S, Vilia MG, Stamatopoulos K, Ghia P, Muzio M: Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies. Semin Cancer Biol. 2016 Aug;39:15-25. Epub 2016 Jul 9. Review. PubMed PMID: 27402288. doi: http://dx.doi.org/10.1016/j.semcancer.2016.07.001
Reference 37 2016
Kavakiotis I, Xochelli A, Agathangelidis A, Tsoumakas G, Maglaveras N, Stamatopoulos K, Hadzidimitriou A, Vlahavas I, Chouvarda I: Integrating multiple immunogenetic data sources for feature extraction and mining somatic hypermutation patterns: the case of “towards analysis” in chronic lymphocytic leukaemia. BMC Bioinformatics. 2016 Jun 6;17 Suppl 5:173. PubMed PMID: 27295298. doi: http://dx.doi.org/10.1186/s12859-016-1044-3
Reference 38 2016
Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, Rossi D, Kminkova J, Stalika E, Pedersen LB, Malcikova J, Agathangelidis A, Davis Z, Mansouri L, Scarfò L, Boudjoghra M, Navarro A, Muggen AF, Yan XJ, Nguyen-Khac F, Larrayoz M, Panagiotidis P, Chiorazzi N, Niemann CU, Belessi C, Campo E, Strefford JC, Langerak […]
Reference 39 2016
Papakonstantinou N, Ntoufa S, Chartomatsidou E, Kotta K, Agathangelidis A, Giassafaki L, Karamanli T, Bele P, Moysiadis T, Baliakas P, Sutton LA, Stavroyianni N, Anagnostopoulos A, Makris AM, Ghia P, Rosenquist R, Stamatopoulos K: The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia. 2016 Jun 14;7(24):35946-35959. PubMed PMID: 27191993. doi: http://dx.doi.org/10.18632/oncotarget.9371
Reference 40 2016
Baliakas P, Puiggros A, Xochelli A, Sutton LA, Nguyen-Khac F, Gardiner A, Plevova K, Minga E, Hadzidimitriou A, Walewska R, McCarthy H, Ortega M, Collado R, González T, Granada I, Luño E, Kotašková J, Moysiadis T, Davis Z, Stavroyianni N, Anagnostopoulos A, Strefford JC, Pospisilova S, Davi F, Athanasiadou A, Rosenquist R, Oscier D, Espinet […]
Reference 30 2016
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil […]
Reference 29 2016
Chatzistamatiou K, Moysiadis T, Moschaki V, Panteleris N, Agorastos T: Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening. Gynecol Oncol. 2016 Jul;142(1):120-7. Epub 2016 May 8. PubMed PMID: 27126005. doi: http://dx.doi.org/10.1016/j.ygyno.2016.04.027